Cargando…

Low serum 1,25(OH)(2)D(3) in end-stage renal disease: is reduced 1α-hydroxylase the only problem?

Low serum 1,25-dihydroxyvitamin D (1,25(OH)(2)D) in end-stage renal disease (ESRD) is considered a consequence of elevated fibroblast growth factor 23 (FGF23) and concomitant reduced activity of renal 1α-hydroxylase (CYP27B1). Current ESRD treatment strategies to increase serum calcium and suppress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huish, Sharon A, Jenkinson, Carl, Dunn, Janet A, Meredith, David J, Bland, Rosemary, Hewison, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558908/ https://www.ncbi.nlm.nih.gov/pubmed/34519274 http://dx.doi.org/10.1530/EC-21-0372

Ejemplares similares

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression
por: Hassan-Smith, Zaki K., et al.
Publicado: (2017)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

The metabolism of 1,25(OH)(2)D(3) in clinical and experimental kidney disease
por: Turner, Mandy E., et al.
Publicado: (2022)

Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)(2)D(3) response to short-term treatment with 1,25-dihydroxyvitamin D(3)in vivo
por: Miao, Dengshun, et al.
Publicado: (2002)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

Without 1α-hydroxylation, the gene expression profile of 25(OH)D(3) treatment overlaps deeply with that of 1,25(OH)(2)D(3) in prostate cancer cells
por: Susa, Takao, et al.
Publicado: (2018)

1,25(OH)(2)D(3) Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept
por: Gardner, David H., et al.
Publicado: (2015)

1,25(OH)(2)D(3) dependent overt hyperactivity phenotype in klotho-hypomorphic mice
por: Leibrock, Christina B., et al.
Publicado: (2016)

Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling
por: Chun, Rene F., et al.
Publicado: (2012)

Epigenetic regulation of the 1,25-dihydroxyvitamin D(3) 24-hydroxylase (CYP24A1) in colon cancer cells
por: Höbaus, Julia, et al.
Publicado: (2013)

Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
por: Jeffery, Louisa E., et al.
Publicado: (2018)

The Impact of Estradiol and 1,25(OH)2D3 on Metabolic Syndrome in Middle-Aged Taiwanese Males
por: Cheng, Kai-Hung, et al.
Publicado: (2013)

1,25 (OH)(2)D(3) treatment alters the granulomatous response in M. tuberculosis infected mice
por: Bhatt, Kamlesh, et al.
Publicado: (2016)

The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
por: Zielińska, Anna, et al.
Publicado: (2021)

Metabolic Advantage of 25(OH)D(3) versus 1,25(OH)(2)D(3) Supplementation in Infantile Nephropathic Cystinosis-Associated Adipose Tissue Browning and Muscle Wasting
por: Zhou, Ping, et al.
Publicado: (2022)

In vitro induction effect of 1,25(OH)(2)D(3) on differentiation of hair follicle stem cell into keratinocyte
por: Joulai Veijouyeh, Sanaz, et al.
Publicado: (2017)

1,25(OH)(2)D(3) Protects Liver Fibrosis Through Decreasing the Generation of TH17 Cells
por: Gu, Lei, et al.
Publicado: (2017)

Anaplastic large cell lymphoma, with 1,25(OH)((2))D((3))-mediated hypercalcemia: A case report
por: Mitobe, Masaki, et al.
Publicado: (2019)

Action of 1,25(OH)(2)D(3) on Human Asthmatic Bronchial Fibroblasts: Implications for Airway Remodeling in Asthma
por: Plesa, Maria, et al.
Publicado: (2020)

Additive Effects of VDBP and 1,25(OH)2D3 on the Viability and Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts
por: Zhang, Yeyong, et al.
Publicado: (2021)

Vitamin D and the Ability to Produce 1,25(OH)(2)D Are Critical for Protection from Viral Infection of the Lungs
por: Arora, Juhi, et al.
Publicado: (2022)

Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase
por: Torremadé, Noelia, et al.
Publicado: (2017)

The Vitamin D Analogue ED71 but Not 1,25(OH)(2)D(3) Targets HIF1α Protein in Osteoclasts
por: Sato, Yuiko, et al.
Publicado: (2014)

Chronic High Fructose Intake Reduces Serum 1,25 (OH)(2)D(3) Levels in Calcium-Sufficient Rodents
por: Douard, Veronique, et al.
Publicado: (2014)

1,25(OH)(2)D(3) Deficiency Induces Colon Inflammation via Secretion of Senescence-Associated Inflammatory Cytokines
por: Liu, Yun, et al.
Publicado: (2016)

Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity
por: Pletz, Mathias W, et al.
Publicado: (2014)

1,25(OH)2D3 treatment attenuates high glucose-induced peritoneal epithelial to mesenchymal transition in mice
por: Yang, Lina, et al.
Publicado: (2017)

Antitumor effects and mechanisms of 1,25(OH)(2)D(3) in the Pfeiffer diffuse large B lymphoma cell line
por: Han, Jing, et al.
Publicado: (2019)

Increased 1,25(OH)(2)-Vitamin D Concentrations after Energy Restriction Are Associated with Changes in Skeletal Muscle Phenotype
por: Vidal, Angela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_asp0fb04sg4b4pkkus4hj83oo7